PQ
PQIA.F RadNet Inc
- Market cap
- EUR 5.33B
- P/E
- -
- P/B
- 5.51x
- ROE
- -2.6%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is PQIA.F undervalued?
Graham numberThe Graham number of RadNet Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
RadNet Inc fundamental analysis
No fundamental analysis for RadNet Inc yet.
RadNet Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About RadNet Inc
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also …
Full company profileRadNet Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
RadNet Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 885M | 922M | 975M | 1.15B | 1.07B | 1.32B | 1.43B | 1.62B | 1.83B | 2.04B | 2.45B |
| Gross Profit | 109M | 120M | 108M | 154M | 106M | 192M | 166M | 221M | 249M | 235M | 265M |
| Operating Income | 42.1M | 53.0M | 34.7M | 73.9M | 45.4M | 104M | 49.8M | 93.0M | 111M | 83.4M | 82.1M |
| EBITDA | - | 134M | 155M | 225M | 200M | 278M | 279M | 293M | 323M | 314M | 287M |
| Net Income | 7.23M | 53.0K | 32.2M | 14.8M | -14.8M | 24.7M | 10.7M | 3.04M | 2.79M | -18.7M | -29.0M |
| EPS | - | 0.00 | 0.66 | 0.29 | -0.29 | 0.46 | 0.18 | 0.04 | 0.04 | -0.24 | -0.37 |
| Balance Sheet | |||||||||||
| Total Assets | 849M | 869M | 1.11B | 1.65B | 1.79B | 2.06B | 2.43B | 2.69B | 3.29B | 3.76B | 4.28B |
| Total Liabilities | 797M | 799M | 909M | 1.41B | 1.53B | 1.71B | 1.94B | 1.88B | 2.15B | 2.40B | 2.84B |
| Shareholders' Equity | 48.5M | 61.6M | 127M | 152M | 166M | 229M | 333M | 631M | 902M | 1.09B | 1.12B |
| Cash & Short-term Investments | 20.6M | 51.3M | 10.4M | 40.2M | 102M | 135M | 128M | 343M | 740M | 767M | 751M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 91.6M | 142M | 117M | 104M | 234M | 149M | 146M | 221M | 233M | 299M | 352M |
| Capital Expenditure | 65.9M | 61.3M | 72.2M | 74.2M | 94.2M | 138M | 119M | 177M | 188M | 213M | 242M |
| Free Cash Flow | - | 53.3M | -28.6M | 3.02M | 108M | -71.2M | -103M | 44.3M | 45.0M | 85.6M | 109M |
| Ratios | |||||||||||
| ROE | 14.9% | 0.1% | 25.4% | 9.7% | -9.0% | 10.8% | 3.2% | 0.5% | 0.3% | -1.7% | -2.6% |
| ROA | 0.9% | 0.0% | 2.9% | 0.9% | -0.8% | 1.2% | 0.4% | 0.1% | 0.1% | -0.5% | -0.7% |
| Net Profit Margin | 0.8% | 0.0% | 3.3% | 1.3% | -1.4% | 1.9% | 0.7% | 0.2% | 0.2% | -0.9% | -1.2% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
RadNet Inc dividends
RadNet Inc has not paid dividends in the last 9 fiscal years.
Who owns RadNet Inc
- Insiders 9.95%
- Institutions 90.05%
- Public & others 0.00%
- Shares outstanding 78.8M
- Free float 65.8M
RadNet Inc company profile
- Company name
- RadNet Inc
- Ticker
- PQIA.F
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 12,000
- Fiscal year end
- December
- Address
- 1510 Cotner Avenue, Los Angeles, CA, United States, 90025
- Phone
- 310 478 7808
- Website
- radnet.com
About RadNet Inc
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretations of breast, lung, and prostate images, as well as solutions for prostate cancer screening. In addition, it develops and delivers AI-powered health informatics solutions to drive quality, efficiency, and outcomes in imaging and radiology; informatics designed for outpatient radiology; and DeepHealth OS, a cloud-native operating system that helps in the operations of the radiology service. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.
RadNet Inc management
10- Dr. Howard G. Berger M.D.Chairman, President & CEO · born 1946
- Mr. Mark D. StolperExecutive VP & CFO · born 1971
- Mr. Mital PatelExecutive VP & COO · born 1986
- Mr. Norman R. HamesPresident & CEO of Western Operations · born 1956
- Mr. Stephen M. ForthuberPresident & CEO of Eastern Operations · born 1961
- Dr. Alma Gregory Sorensen M.D.Executive VP, Chief Strategy Officer & Director · born 1962
- Ms. Susan HollabaughChief Information Officer
- Mr. David Jeffrey Katz Esq.Executive VP, Chief Legal Officer & Corporate Secretary · born 1964
- Mr. David ManheimSenior VP & Chief Compliance Officer
- Mr. Michael M. MurdockExecutive Vice President of Mergers & Acquisitions · born 1955